Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD): Pilot, Randomized and Controlled Clinical Trial - OCD-RT

CCAB Centro Clinico Academico Braga Associacao0 个研究点目标入组 48 人开始时间: 2024年3月4日最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•Patients diagnosed with OCD according to DSM-5 and/or ICD-10 criteria., Age between 18 and 64 years old, European Portuguese as mother tongue, Score = 16 on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Have demonstrated resistance to first-line treatments for OCD, as defined by: Lack of response to pharmacological treatment with at least two selective serotonin reuptake inhibitors (SSRIs) at the maximum tolerated therapeutic dose (Fluoxetine 40-60mg/day; Fluvoxamine 100-300mg/day; Escitalopram 10-30mg/day; Citalopram 20-60 mg/day; Paroxetine 40-60mg/day and Sertraline 100-300mg/day) for at least 12 weeks, i.e., patients who show less than a 25% reduction in Y-BOCS score compared to the score obtained before starting SSRI treatment or patients who maintain a score = 16 on the Y-BOCS after SSRI treatment; and Lack of response to pharmacological treatment with risperidone or aripiprazole as augmentation of SSRIs at the maximum tolerated therapeutic dose (Risperidone 0.5-4 mg/day, Aripiprazole 5-15 mg/day) for at least 6 to 12 weeks, i.e., patients who show less than a 25% reduction in Y-BOCS score compared to the score obtained before starting antipsychotic treatment or patients who maintain a score = 16 on the Y-BOCS after antipsychotic treatment., In the case of participants of childbearing potential, it is necessary for them to consistently and correctly use one of the contraceptive methods presented in section 4.4.1.

•Patients with a current or previous history of psychotic illness (schizophrenia, delusions, among others), Hypotension (<90/60 mmHg) in the sitting position and orthostatic hypotension (drop in systolic BP =20 mmHg or diastolic BP =10 mmHg after 2-3 minutes in standing position) at the screening appointment;, Patients with bipolar disorder, Patients with tic disorders, Patients with borderline personality disorder, Patients with social anxiety disorder, Patients with a current or previous history of eating disorder in the last 6 months, Patients with a history of neurological disease or traumatic brain injury, Patients with a history of alcohol or illicit substance abuse in the last 6 months, Patients who are experiencing or have experienced a major depressive episode in the last 6 months, Patients with contraindications to undergo MRI cannot participate in the assessment of the exploratory endpoint, Patients undergoing deep brain stimulation, Presence of sensory deficits that prevent participation in the clinical study, Pregnant or breastfeeding women, Patients who are undergoing or have undergone psychotherapy in the last 6 months, Patients taking medication or receiving prohibited treatments, Allergy to pramipexole and any of its excipients, Patients with creatinine clearance = 50 ml/min (calculated using the Cockcroft-Gault formula), Patients with NYHA III or IV heart failure or any other severe cardiovascular disease

发起方

CCAB Centro Clinico Academico Braga Associacao